Top Wall Street Stories: Sage Therapeutics, Inc. (NASDAQ:SAGE), Celator Pharmaceuticals, Inc. (NASDAQ:CPXX), Carrizo Oil & Gas Inc. (NASDAQ:CRZO), Delta Natural Gas Company, Inc. (NASDAQ:DGAS),

Sage Therapeutics (NASDAQ:SAGE), announced that Jeff Jonas, M.D., Chief Executive Officer of Sage, will present at the Cowen & Co. 36th Annual Health Care Conference at 4:00 PM ET on Monday, March 7, 2016, in Boston.

Sage Therapeutics, Inc. (NASDAQ:SAGE) belongs to Healthcare sector. Its weekly performance is -6.04%. On last trading day company shares ended up at $30.17.

On 16 February, Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) announced that the Phase 3 clinical trial of VYXEOS™ (cytarabine:daunorubicin) Liposome for Injection (also known as CPX-351) in patients with untreated high-risk (secondary) acute myeloid leukemia (AML) has reached its pre-specified number of events required for the analysis of overall survival. The company expects to announce overall survival results later this quarter.

Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) shares moved down -11.68% in last trading session and ended the day at $1.89. CPXX return on assets is -53.40%. Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) quarterly performance is 4.42%.

On 22 February, Carrizo Oil & Gas Inc. (NASDAQ:CRZO) reported a fourth quarter of 2015 loss from continuing operations of $380.7 million, or $6.73 per basic and diluted share compared to income from continuing operations of $129.5 million, or $2.84 and $2.79 per basic and diluted share, respectively, in the fourth quarter of 2014. The loss from continuing operations for the fourth quarter of 2015 includes certain items typically excluded from published estimates by the investment community, including the full cost ceiling test impairment recognized this quarter.

On 01 March, Carrizo Oil & Gas Inc. (NASDAQ:CRZO) shares advanced 0.23% and was closed at $21.55. CRZO EPS growth in last 5 year was 8.73%. Carrizo Oil & Gas Inc. (NASDAQ:CRZO) year to date (YTD) performance is -27.15%.

The board of directors of Delta Natural Gas Company, Inc. (NASDAQ:DGAS) at a meeting held February 12, 2016, authorized a quarterly dividend of twenty and one-half cents ($.205) per share of common stock to be paid March 15, 2016 to all common shareholders of record as of March 1, 2016.

Delta Natural Gas Company, Inc. (NASDAQ:DGAS) ended the last trading day at $22.85. Company weekly volatility is calculated as 2.98% and price to cash ratio as 17.95. Delta Natural Gas Company, Inc. (NASDAQ:DGAS) showed a weekly performance of 0.09%.

Harte Hanks (NYSE: HHS) reported that its board of directors has declared a regular quarterly cash dividend of 8.5 cents per share payable on March 15, 2016, to the holders of record of the company’s common stock at the close of business on March 1, 2016.

Harte-Hanks Inc. (NYSE:HHS) shares advanced 2.91% in last trading session and ended the day at $3.18. HHS Gross Margin is 18.40% and its return on assets is -29.00%. Harte-Hanks Inc. (NYSE:HHS) quarterly performance is -10.24%.

Leave a Reply

Your email address will not be published. Required fields are marked *